Precision modelling of FHHNC using patient-derived kidney organoids for mechanistic and therapeutic discovery VHIR is seeking an outstanding and highly motivated postdoctoral researcher to apply for a Marie Sklodowska-Curie Postdoctoral Fellowship and join the Kidney Pathophysiology
Inhibition of mitochondrial sodium/calcium exchanger, NCLX, as a therapeutic strategy to reduce myocardial ischemia-reperfusion injury during myocardial infarction VHIR is seeking an outstanding and highly motivated postdoctoral researcher to apply for a Marie Sklodowska-Curie Postdoctoral Fellowship
Identification and Genetic Engineering of Cytotoxic Tissue NK Cells for Cellular Therapy The Infectious Diseases Research Group at the Vall dHebron Research Institute (VHIR), Barcelona, is seeking an outstanding postdoctoral researcher interested in developing competitive applications for
NEURO-immune and GATEway-mediated mechanisms to counteract Parkinson’s Disease (NEUROGATE-PD) VHIR is seeking an outstanding and highly motivated postdoctoral researcher to apply for a Marie Sklodowska-Curie Postdoctoral Fellowship and join the Neurodegenerative Disorders Research Group. Marie Skłodowska-Curie
Deciphering the neurotoxic mechanisms of chitinase 3-like 1 (CHI3L1) in progressive multiple sclerosis and identification of therapeutic compounds blocking its pathogenic effects VHIR is seeking an outstanding and highly motivated postdoctoral researcher to apply for a
Overview Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore
The Barcelona Institute for Global Health (ISGlobal) is a cutting-edge institute addressing global public health challenges through research, translation into policy and education. ISGlobal has a broad portfolio in communicable and non-communicable diseases including environmental and
Who We Are Ozelle is a diagnostic technology company advancing the fourth generation of hematology analysis through AI × Complete Blood Morphology (AI × CBM). Founded in Silicon Valley in 2014, we combine high-resolution cellular imaging with AI
Inhibition of mitochondrial sodium/calcium exchanger, NCLX, as a therapeutic strategy to reduce myocardial ischemia-reperfusion injury during myocardial infarction Dé el siguiente paso en su carrera profesional ahora: desplácese hacia abajo para leer la descripción completa del
Who We Are Todas las habilidades, cualificaciones y experiencia relevantes que necesitará un candidato seleccionado se enumeran en la siguiente descripción. Ozelle is a diagnostic technology company advancing the fourth generation of hematology analysis through AI
Who We Are Todas las habilidades, cualificaciones y experiencia relevantes que necesitará un candidato seleccionado se enumeran en la siguiente descripción. Ozelle is a diagnostic technology company advancing the fourth generation of hematology analysis through AI
Who We Are Todas las habilidades, cualificaciones y experiencia relevantes que necesitará un candidato seleccionado se enumeran en la siguiente descripción. Ozelle is a diagnostic technology company advancing the fourth generation of hematology analysis through AI
Who We Are Ozelle is a diagnostic technology company advancing the fourth generation of hematology analysis through AI × Complete Blood Morphology (AI × CBM). Founded in Silicon Valley in 2014, we combine high-resolution cellular imaging with AI
Who We Are Ozelle is a diagnostic technology company advancing the fourth generation of hematology analysis through AI × Complete Blood Morphology (AI × CBM). Founded in Silicon Valley in 2014, we combine high-resolution cellular imaging with AI
Who We Are Ozelle is a diagnostic technology company advancing the fourth generation of hematology analysis through AI × Complete Blood Morphology (AI × CBM). Founded in Silicon Valley in 2014, we combine high-resolution cellular imaging with AI
Who We Are Ozelle is a diagnostic technology company advancing the fourth generation of hematology analysis through AI × Complete Blood Morphology (AI × CBM). Founded in Silicon Valley in 2014, we combine high-resolution cellular imaging with AI
Who We Are Ozelle is a diagnostic technology company advancing the fourth generation of hematology analysis through AI × Complete Blood Morphology (AI × CBM). Founded in Silicon Valley in 2014, we combine high-resolution cellular imaging with AI
Who We Are Ozelle is a diagnostic technology company advancing the fourth generation of hematology analysis through AI × Complete Blood Morphology (AI × CBM). Founded in Silicon Valley in 2014, we combine high-resolution cellular imaging with AI
Who We Are Ozelle is a diagnostic technology company advancing the fourth generation of hematology analysis through AI × Complete Blood Morphology (AI × CBM). Founded in Silicon Valley in 2014, we combine high-resolution cellular imaging with AI
Who We Are Ozelle is a diagnostic technology company advancing the fourth generation of hematology analysis through AI × Complete Blood Morphology (AI × CBM). Founded in Silicon Valley in 2014, we combine high-resolution cellular imaging with AI